首页 | 本学科首页   官方微博 | 高级检索  
     


Radiothérapie stéréotaxique de carcinomes bronchiques primitifs : suivi non invasif de la cible en temps réel
Authors:J.E. Bibault   B. Prevost   E. Dansin   X. Mirabel   T. Lacornerie   F. Dubus  E. Lartigau  
Affiliation:a Département universitaire de radiothérapie, université Lille II, CyberKnife Nord-Ouest, centre Oscar-Lambret, 3, rue Frédéric-Combemale, BP 307, 59020 Lille cedex, France;b Département d’oncologie générale, centre Oscar-Lambret, 3, rue Frédéric-Combemale, BP 307, 59020 Lille cedex, France
Abstract:PurposeStereotactic radiation therapy using the CyberKnife® has been introduced in France in 2006. Two treatment modalities are currently available: the first one (Synchrony®) is a real-time fiducial-based target tracking system, while the other (Xsight Lung Tracking [XLT] System®) is completely fiducial-free.Patients and methodsSixty-eight patients were treated for a pulmonary tumor between June 2007 and November 2009. Since august 2008, the XLT System® was used for 26 patients. We report the necessary conditions for the XLT System (position, laterality and size of the tumor), the toxicity and outcome of this treatment.ResultsTwenty-two patients were analyzed. Median follow-up was 6 months (min = 3; max = 16). Local control rate was 100%. The main toxicity was grade grade 1 pulmonary alveolitis (27%). No grade 3 or 4 toxicities were reported.ConclusionThe high local control rate and low toxicity obtained with the CyberKnife® XLT System® suggest that such treatment is an alternative for inoperable patients.
Keywords:Mots clé  s: CyberKnife   Radiothé  rapie sté    otaxique hypofractionné  e   Synchrony   Xsight Lung Tracking System   Cancer bronchopulmonaire   Efficacité     Toxicité  CyberKnife   Stereotactic hypofractionated radiotherapy   Synchrony   Xsight Lung Tracking System   Lung Cancer   Outcome   Toxicity
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号